Disease
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 20, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a terminated study registration with feasibility endpoints only; no results are reported in the registry record, precluding any assessment of efficacy or harm.
AUG 20, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 trial in a recruiting stage with no results reported; measures a surrogate endpoint (ctDNA clearance) in an adjuvant minimal residual disease setting.
AUG 17, 2026 · PHASE 4 TRIAL
ClinicalTrials.gov
This is a Phase 4 interventional trial registration with no reported results; the study is not yet recruiting and carries planned outcome measures only.
AUG 14, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a clinical trial registry record describing a planned interventional study with no results posted; it represents the study design and rationale only, not evidence of efficacy.
AUG 14, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
A feasibility study with no posted results assessing exercise adherence and retention in older women with breast cancer during chemotherapy; designed to test implementation rather than clinical efficacy.
AUG 10, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a registry record for an active interventional feasibility study with no results yet posted; it describes planned enrollment and outcome measures only, making it a preliminary report of work in progress.